"using simulation with scheduling visualization to evaluate change initiatives in a bio-pharma...

29
"Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio- Pharma Environment”

Upload: eustacia-carson

Post on 17-Jan-2016

226 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

"Using Simulation with Scheduling Visualization to

evaluate Change Initiatives in a Bio-Pharma Environment”

Page 2: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Topics

• The issues

• Solution objectives

• Solution components

• The first test

• The first answer

• Tangible benefits

• Intangible benefits

Page 3: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The Issues• Pharmaceutical manufacturing processes

are complex and subject to a unique set of challenges

• “Delicate” product that is subject to • Expiry constraints • Contamination• Strict environmental condition requirements• High production costs• High revenue loss for rejects

Page 4: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The Issues (cont’d)

• Equipment use and management is also subject to constraints

• Clean and Dirty hold times• Re-use in multiple steps• Highly specialized• High cost • Limited maintenance/cleanliness facilities

Page 5: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The Issues (cont’d)

• Personnel issues include• Specialization and certification for tasks• Gowning De-Gowning• Critical scheduling• Burnout

Page 6: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The Issues (cont’d)

• The process• Relatively long cycle time• Multiple testing and reject points• “Re-work” usually not an option• Complex timing of steps• Not conducive to automation• Inherent inefficiencies • Many steps require task executor and observer • Change requires “act of congress”

Page 7: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The Issues (cont’d)

• The consequences• Communication of process via “village folklore”• ISO - TTWWHADI• Process change impact in real world expensive • Vulnerable to personnel turnover• Stagnant process – “if it ain’t broke don’t fix it”

stance limiting• Difficult to identify relationships between issues

Page 8: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Objectives

…. to provide an organizational capability to more accurately predict the production throughput of a production process while considering the many variables that can effect the system.

Page 9: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Objectives (cont’d)• Two main phases :

1. Provide a means to represent and visualize the way the process is today

2. Provide a means to identify opportunities (using scenarios) for process modifications and quantify their impact by changing :

1. The process itself2. Shift schedules3. Production schedules4. Resource requirements5. Task cycle times6. Variability

Page 10: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Objectives (cont’d)

• Main requirements :1. Flexible input modules using MS Visio and Excel

2. Minimize changes to model required for scenario evaluation

3. Rapid what-if analysis capability

4. Gantt chart visualization of model output

Page 11: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution ComponentsMicrosoft Visio

Diagram

Export to Microsoft Excel Worksheet

PROMODEL Model

Use as backdrop for

Provide data to

Orchestrate Project

Supply Gantt chart data to

Provide infrastructure

data to

PROMODEL Output

Statistics Database

Populate

Page 12: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Components (cont’d)

• MS Visio Diagram :• Represented the process flow using a

nomenclature standard and simple relationship mechanisms

• Included Visual Basic “export” function to export task information to MS Excel worksheet

• Identified “trigger tasks”

Page 13: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Components (MS Visio)

Page 14: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Components (cont’d)

• MS Excel Worksheet :• Multiple “hidden” sheets acted as link between

Visio Diagram and ProModel model• Provided means to enter :

» Task cycle times» Resource/task assignment and utilization» Resource information (shifts, qty available, type)» Production schedule (identical format to client

report)» Trigger task information

• Orchestrate infrastructure

Page 15: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Components (Excel Input)

Page 16: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Components (cont’d)

• ProModel Model :• Visio diagram used as background• Makes exclusive use of excel worksheet data for

routing, cycle time and resource information• Linked to Orchestrate project file• Standard output statistics keeping track of :

» System throughput» Overall Cycle Time» Work In Process» Utility Consumption (WFI)» Resource Utilization

Page 17: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Components (cont’d)Running Solution

Page 18: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Components (cont’d)

• Orchestrate Project File :• Linked to model to provide Gantt visualization of

model events and measurements• Infrastructure information maintained in MS Excel

input workbook• Updated in real time with model progress• Tracked :

» Batch production progress» Task events» Resource states» Key metrics

Page 19: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Solution Components (cont’d)Orchestrate Schedule Visualization

Page 20: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The First Test

• During technology transfer training, a senior production manager asked if the model could examine the possibility of going from a two to a three shift operation with batches being initiated back to back as opposed to the normal “one start a week” ……

Page 21: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The First Test (cont’d)

…. Oh, and by the way, can you give me the answer by tomorrow?

Page 22: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The First Test (cont’d)

More specifically :– Could the solution handle the complexity of

scheduling the complicated, highly variable prep steps to take advantage of the third shift ?

– Could a batch be completed in less than a 5 day week in the new scenario ?

– Would this increase the production capacity linearly or by least 50% ?

– Would the increased production be worth they investment?

Page 23: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The First Answer

• Together with a client SME, and a ProModel consultant, the answer was obtained in the matter of a few hours.

• Normally, this question would have taken weeks to answer.

Page 24: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The First Answer (cont’d)More specifically :

• Confirmed the model & user could schedule the complicated highly variable prep steps

• Confirmed a batch be completed in less than 5 days, in fact the average time to complete was 4 days and 10 hours.

• Confirmed adding the 3rd shift would increase the production capacity counter intuitively far beyond 50%

Page 25: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The First Answer (cont’d)

Page 26: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

The First Answer (cont’d)

Average Batch Throughput

0

10

20

30

40

50

60

70

80

90

1 19 37 55 73 91 109

127

145

163

181

199

217

235

253

271

289

307

325

343

361

Days

Bat

ches

Co

mlt

ed

Throughput (2 Shift) Throughput (3 Shift)

The additional counter intuitive capacity (over 100%) came from providing the client with the ability to schedule and manage the highly variable “Prep Steps” in a much more dependable fashion such as•Reduced batch loss due to expiry•Optimization of feeding constraining resources.

Confirmed adding the 3rd shift would increase the production capacity counter intuitively far beyond 50%

Page 27: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Tangible Benefits• Going from a two shift to a three shift

operation would theoretically enable the facility to produce 1 batch per week versus .5 batches per week resulting in an increase in revenue in the tens of millions …. annually.

• The client team now has the ability to analyze their process on a virtual test bed before submitting proposed changes.

Page 28: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

Intangible Benefits

• The architecture used on this project is widely “reusable”.

• The client was now familiar with process modeling and could leverage this knowledge to study other production processes (which they are doing).

• “Proof of concept” aspect created visibility opportunities for the client team.

Page 29: "Using Simulation with Scheduling Visualization to evaluate Change Initiatives in a Bio-Pharma Environment”

• Questions???